Home / Stocks / DOCU

DocuSign (DOCU, Application Software) Stock Valuation & Fair Value Favorable on our tests

DocuSign (DOCU, Application Software) trades at a blended P/E of 15.8, a multiple its historical normal P/E is too distorted to compare with, with a forward growth estimate of 12.7% and a PEG of 1.25. Analysts' one-year estimates have been hit 29% of the time.

The historical normal P/E published for DocuSign is 108.8, more than six times its current multiple. A gap that wide comes from the company's earnings history rather than from its price, so this page quotes no premium or discount against it.

DATA AS OF 2026-10-05
Blended P/E
15.8
Normal P/E
not meaningful
PEG
1.25
Fwd growth
12.7%
Div yield
0.0%
RSI (14)
61.6
Neutral
Technical context
  • Price $71.43 at the 2026-10-08 close, 3.7% above the 20-day average ($68.86) and 11.0% above the 50-day ($64.38).
  • RSI (14) at 61.6.
  • 52-week range $41.75 to $73.14: the price is 2.3% below the high and 71.1% above the low.

The Street vs SeerForecast

Wall Street's mean price target for DOCU is $69.99 across 16 analysts, 2.0% below the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from strong on our tests (2026-07-25) to favorable on our tests (2026-10-05).

Blended P/E and rating by weekBlended P/E moved from 12.1 to 15.8 between 2026-07-24 and 2026-10-02, with 3 rating changes over 24 recorded weeks.2026-07-24: P/E 12.1, Strong on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 12.1, Strong on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 13.0, Favorable on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 13.1, Favorable on our tests, recorded live 2026-08-032026-08-07: P/E 13.6, Favorable on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 14.3, Favorable on our tests, recorded live 2026-08-102026-08-14: P/E 15.2, Favorable on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 14.7, Favorable on our tests, recorded live 2026-08-172026-08-21: P/E 14.8, Favorable on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 14.7, Favorable on our tests, recorded live 2026-08-242026-08-27: P/E 14.7, Favorable on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 15.1, Favorable on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 15.1, Favorable on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 15.1, Favorable on our tests, recorded live 2026-08-312026-09-04: P/E 15.9, Favorable on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 15.9, Favorable on our tests, recorded live 2026-09-072026-09-11: P/E 15.2, Favorable on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 15.2, Favorable on our tests, recorded live 2026-09-142026-09-18: P/E 15.9, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 15.9, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 15.5, Favorable on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 15.5, Favorable on our tests, recorded live 2026-09-282026-10-02: P/E 15.8, Favorable on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 15.8, Favorable on our tests, recorded live 2026-10-0513.014.015.0Jul 24Aug 11Aug 28Sep 14Oct 2
Strong on our testsFavorable on our testsMixed on our testsLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-25P/E 12.1not meaningfulStrong on our tests (recalculated)
2026-07-31P/E 13.0not meaningfulFavorable on our tests (recalculated)
2026-09-05P/E 15.9not meaningfulFavorable on our tests (recalculated)
2026-09-19P/E 15.9not meaningfulMixed on our tests (recalculated)
2026-09-26P/E 15.5not meaningfulFavorable on our tests (recalculated)
2026-10-05P/E 15.8not meaningfulFavorable on our tests ← now
Show all 24 weeks
WeekBlended P/EPremium to normal P/ERating
2026-07-25P/E 12.1not meaningfulStrong on our tests (recalculated)
2026-07-27P/E 12.1not meaningfulStrong on our tests (recalculated)
2026-07-31P/E 13.0not meaningfulFavorable on our tests (recalculated)
2026-08-03P/E 13.1not meaningfulFavorable on our tests
2026-08-07P/E 13.6not meaningfulFavorable on our tests (recalculated)
2026-08-10P/E 14.3not meaningfulFavorable on our tests
2026-08-14P/E 15.2not meaningfulFavorable on our tests (recalculated)
2026-08-17P/E 14.7not meaningfulFavorable on our tests
2026-08-21P/E 14.8not meaningfulFavorable on our tests (recalculated)
2026-08-24P/E 14.7not meaningfulFavorable on our tests
2026-08-27P/E 14.7not meaningfulFavorable on our tests (recalculated)
2026-08-28P/E 15.1not meaningfulFavorable on our tests (recalculated)
2026-08-30P/E 15.1not meaningfulFavorable on our tests (recalculated)
2026-08-31P/E 15.1not meaningfulFavorable on our tests
2026-09-05P/E 15.9not meaningfulFavorable on our tests (recalculated)
2026-09-07P/E 15.9not meaningfulFavorable on our tests
2026-09-12P/E 15.2not meaningfulFavorable on our tests (recalculated)
2026-09-14P/E 15.2not meaningfulFavorable on our tests
2026-09-19P/E 15.9not meaningfulMixed on our tests (recalculated)
2026-09-21P/E 15.9not meaningfulMixed on our tests
2026-09-26P/E 15.5not meaningfulFavorable on our tests (recalculated)
2026-09-28P/E 15.5not meaningfulFavorable on our tests
2026-10-03P/E 15.8not meaningfulFavorable on our tests (recalculated)
2026-10-05P/E 15.8not meaningfulFavorable on our tests ← now

Frequently asked questions

Is DocuSign stock overvalued?

DocuSign trades at a blended P/E of 15.8, with a PEG of 1.25 on 12.7% forward growth. Its published historical normal P/E is 108.8, more than six times that, so there is no meaningful premium or discount to quote. tickerseer currently rates it favorable on our tests.

What is DocuSign's fair value and PEG?

DocuSign trades at a blended P/E of 15.8, a PEG of 1.25, and a forward growth estimate of 12.7%.

Has tickerseer's rating of DocuSign changed?

tickerseer's rating moved from strong on our tests (2026-07-25) to favorable on our tests (2026-10-05).

What is the analyst price target for DocuSign?

The mean Wall Street price target for DocuSign is $69.99 across 16 analysts, 2.0% below the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Application Software. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track DOCU free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.